Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):767-8. doi: 10.1016/j.jaip.2016.02.005. Epub 2016 Mar 26.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage*
  • Biopsy
  • Budesonide / administration & dosage*
  • Child
  • Child, Preschool
  • Eosinophilic Esophagitis / drug therapy*
  • Eosinophilic Esophagitis / pathology
  • Esophagus / pathology
  • Fruit
  • Honey
  • Humans
  • Infant
  • Pharmaceutical Vehicles / administration & dosage
  • Sucrose / administration & dosage
  • Sucrose / analogs & derivatives
  • Sweetening Agents / administration & dosage

Substances

  • Anti-Inflammatory Agents
  • Pharmaceutical Vehicles
  • Sweetening Agents
  • Budesonide
  • Sucrose
  • trichlorosucrose